These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 37069718)
1. Reprogramming of Lipid Metabolism in Cancer: New Insight into Pathogenesis and Therapeutic Strategies. Saikia S; Ahmed F; Prajapati BG; Padma VV; Chorawala MR; Postwala HI; Bhattacharya S Curr Pharm Biotechnol; 2023; 24(15):1847-1858. PubMed ID: 37069718 [TBL] [Abstract][Full Text] [Related]
2. Lipid metabolism reprogramming and its potential targets in cancer. Cheng C; Geng F; Cheng X; Guo D Cancer Commun (Lond); 2018 May; 38(1):27. PubMed ID: 29784041 [TBL] [Abstract][Full Text] [Related]
3. Targeting lipid metabolism in the treatment of ovarian cancer. Chaudhry S; Thomas SN; Simmons GE Oncotarget; 2022; 13():768-783. PubMed ID: 35634242 [TBL] [Abstract][Full Text] [Related]
4. Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention. Butler LM; Perone Y; Dehairs J; Lupien LE; de Laat V; Talebi A; Loda M; Kinlaw WB; Swinnen JV Adv Drug Deliv Rev; 2020; 159():245-293. PubMed ID: 32711004 [TBL] [Abstract][Full Text] [Related]
5. New dawn for cancer cell death: Emerging role of lipid metabolism. Zhang C; Zhu N; Li H; Gong Y; Gu J; Shi Y; Liao D; Wang W; Dai A; Qin L Mol Metab; 2022 Sep; 63():101529. PubMed ID: 35714911 [TBL] [Abstract][Full Text] [Related]
6. Cancer cells differentially activate and thrive on de novo lipid synthesis pathways in a low-lipid environment. Daniëls VW; Smans K; Royaux I; Chypre M; Swinnen JV; Zaidi N PLoS One; 2014; 9(9):e106913. PubMed ID: 25215509 [TBL] [Abstract][Full Text] [Related]
7. Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy. Wu Y; Pu X; Wang X; Xu M Lipids Health Dis; 2024 Feb; 23(1):35. PubMed ID: 38302980 [TBL] [Abstract][Full Text] [Related]
8. Lipid desaturation - the next step in targeting lipogenesis in cancer? Peck B; Schulze A FEBS J; 2016 Aug; 283(15):2767-78. PubMed ID: 26881388 [TBL] [Abstract][Full Text] [Related]
9. Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer. Snaebjornsson MT; Janaki-Raman S; Schulze A Cell Metab; 2020 Jan; 31(1):62-76. PubMed ID: 31813823 [TBL] [Abstract][Full Text] [Related]
10. The Role of Lipid Metabolism Disorders in the Development of Thyroid Cancer. Lukasiewicz M; Zwara A; Kowalski J; Mika A; Hellmann A Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000236 [TBL] [Abstract][Full Text] [Related]
11. Lipid Metabolism and Mitochondria: Cross Talk in Cancer. Srivastava A; Srivastava P; Mathur S; Abbas S; Rai N; Tiwari S; Tiwari M; Sharma L Curr Drug Targets; 2022; 23(6):606-627. PubMed ID: 34431462 [TBL] [Abstract][Full Text] [Related]
12. Alterations of Fatty Acid Profile May Contribute to Dyslipidemia in Chronic Kidney Disease by Influencing Hepatocyte Metabolism. Czumaj A; Śledziński T; Carrero JJ; Stepnowski P; Sikorska-Wisniewska M; Chmielewski M; Mika A Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109090 [TBL] [Abstract][Full Text] [Related]
13. Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids. Zaidi N; Lupien L; Kuemmerle NB; Kinlaw WB; Swinnen JV; Smans K Prog Lipid Res; 2013 Oct; 52(4):585-9. PubMed ID: 24001676 [TBL] [Abstract][Full Text] [Related]
14. Targeting dysregulated lipid metabolism in the tumor microenvironment. Kim DH; Song NY; Yim H Arch Pharm Res; 2023 Dec; 46(11-12):855-881. PubMed ID: 38060103 [TBL] [Abstract][Full Text] [Related]
15. Fatty acid binding protein 5 regulates lipogenesis and tumor growth in lung adenocarcinoma. Garcia KA; Costa ML; Lacunza E; Martinez ME; Corsico B; Scaglia N Life Sci; 2022 Jul; 301():120621. PubMed ID: 35545133 [TBL] [Abstract][Full Text] [Related]
16. Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolism. Gómez de Cedrón M; Ramírez de Molina A J Lipid Res; 2016 Feb; 57(2):193-206. PubMed ID: 26630911 [TBL] [Abstract][Full Text] [Related]
17. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways. Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231 [TBL] [Abstract][Full Text] [Related]
18. Complex Alterations of Fatty Acid Metabolism and Phospholipidome Uncovered in Isolated Colon Cancer Epithelial Cells. Hofmanová J; Slavík J; Ciganek M; Ovesná P; Tylichová Z; Karasová M; Zapletal O; Straková N; Procházková J; Bouchal J; Kolář Z; Ehrmann J; Levková M; Hušková Z; Skalický P; Kozubík A; Machala M; Vondráček J Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206240 [TBL] [Abstract][Full Text] [Related]
19. Exogenous lipids promote the growth of breast cancer cells via CD36. Zhao J; Zhi Z; Wang C; Xing H; Song G; Yu X; Zhu Y; Wang X; Zhang X; Di Y Oncol Rep; 2017 Oct; 38(4):2105-2115. PubMed ID: 28765876 [TBL] [Abstract][Full Text] [Related]
20. Human Cytomegalovirus Uses a Host Stress Response To Balance the Elongation of Saturated/Monounsaturated and Polyunsaturated Very-Long-Chain Fatty Acids. Xi Y; Lindenmayer L; Kline I; von Einem J; Purdy JG mBio; 2021 May; 12(3):. PubMed ID: 33947752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]